Antioxidants and cardiovascular disease: a review.

In spite of the significant decline in cardiovascular disease (CVD) mortality over the past several decades, CVD remains the leading cause of death in the United States. Although age-specific CVD rates are higher in men than women, CVD is nonetheless the leading cause of death for both sexes, and is responsible for approximately one-third of all fatalities in women as well as men. Antioxidant vitamins are a promising area of current research in the prevention of CVD. The postulated mechanism for such an effect derives from basic research demonstrating the ability of antioxidants to inhibit the oxidation of low-density lipoprotein cholesterol. Epidemiologic studies that have explored the antioxidant vitamin hypothesis include descriptive and cross-sectional studies, analytic investigations using case-control and prospective cohort study designs, as well as several small randomized clinical trials. Findings from these studies are not totally consistent, but generally support the hypothesis that antioxidant vitamins reduce the risk of CVD. Overall, there are fewer data in women than men. Large-scale randomized trials are now ongoing that will provide reliable evidence on this question. The ongoing Physicians' Health Study of over 22,000 men is testing beta-carotene, while the recently begun Women's Health Study of 40,000 women will test, utilizing a factorial design, beta-carotene as well as vitamin E. A trial has also recently been funded to test beta-carotene, vitamin E and vitamin C in secondary prevention among a high-risk population of 8,000 women with prior CVD events.(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  K. Haeger Long-time treatment of intermittent claudication with vitamin E , 1974 .

[2]  D. Steinberg,et al.  Antioxidants in the prevention of human atherosclerosis. Summary of the proceedings of a National Heart, Lung, and Blood Institute Workshop: September 5-6, 1991, Bethesda, Maryland. , 1992, Circulation.

[3]  J. Steinberg Book ReviewAmbulatory Pediatric Care , 1989 .

[4]  T. Smith,et al.  Effect of dietary vitamin E on plasma lipids and atherogenesis in restricted ovulator chickens. , 1989, Atherosclerosis.

[5]  J L Witztum,et al.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.

[6]  T. Carew,et al.  Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Kapeghian,et al.  Fruit and vegetable consumption and cardiovascular mortality. , 1985, Medical hypotheses.

[8]  A. Adelstein,et al.  Commodity consumption and ischemic heart disease mortality, with special reference to dietary practices. , 1975, Journal of chronic diseases.

[9]  E. Ginter Decline of coronary mortality in United States and vitamin C. , 1979, The American journal of clinical nutrition.

[10]  P. Livingstone,et al.  Treatment of intermittent claudication with vitamin E. , 1958, Lancet.

[11]  Baron Jh PEPTIC ULCER , 1975, The Lancet.

[12]  A. Hofman,et al.  Serum selenium, vitamin antioxidants, and cardiovascular mortality: a 9-year follow-up study in the Netherlands. , 1987, The American journal of clinical nutrition.

[13]  Heikki Korpela,et al.  High Stored Iron Levels Are Associated With Excess Risk of Myocardial Infarction in Eastern Finnish Men , 1992, Circulation.

[14]  Verlangieri Aj,et al.  Effects of d-alpha-tocopherol supplementation on experimentally induced primate atherosclerosis. , 1992 .

[15]  J. Salonen,et al.  Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease. , 1985, The American journal of cardiology.

[16]  N. Flowers,et al.  Leukocyte ascorbic acid and its relationship to coronary artery disease in man. , 1980, The American journal of clinical nutrition.

[17]  A. Comas Letter: Dermatoglyphic nomogram in diagnosis of trisomy 21. , 1974, Lancet.

[18]  J. Warbasse,et al.  Quantitative evaluation of vitamin E in the treatment of angina pectoris. , 1977, American heart journal.

[19]  D. Wood,et al.  Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene , 1991, The Lancet.

[20]  J. Enstrom,et al.  Vitamin C Intake and Mortality among a Sample of the United States Population , 1992, Epidemiology.

[21]  H. Stähelin,et al.  Plasma levels of antioxidant vitamins in relation to ischemic heart disease and cancer. , 1987, The American journal of clinical nutrition.

[22]  S. Juźwiak,et al.  Effect of selenium and vitamin E on the development of experimental atherosclerosis in rabbits. , 1991, Atherosclerosis.

[23]  J. Manson,et al.  Dietary Antioxidants and Cardiovascular Disease , 1992, Annals of the New York Academy of Sciences.

[24]  C. Hennekens,et al.  Vitamin antioxidants and cardiovascular disease , 1992 .

[25]  R. Elton,et al.  Plasma antioxidants and coronary heart disease: vitamins C and E, and selenium. , 1990, European journal of clinical nutrition.

[26]  R. Acheson,et al.  DOES CONSUMPTION OF FRUIT AND VEGETABLES PROTECT AGAINST STROKE? , 1983, The Lancet.